Stocks TelegraphStocks Telegraph
Stock Ideas

TFX Company Profile and Key Details

NYSE : TFX

Teleflex

$106.21
-2.21-2.04%
At Close 4:00 PM
55.41
B-ESG ScoreESG Rating

Price Chart

Stock Price Today

Teleflex Incorporated (TFX) stock declined over -2.04%, trading at $106.21 on NYSE, down from the previous close of $108.42. The stock opened at $107.82, fluctuating between $104.03 and $108.92 in the recent session.

Stock Snapshot

108.42
Prev. Close
4.69B
Market Cap
104.0301
Day Low
-14.81
P/E Ratio
-7.17
EPS (TTM)
8.92
Cash Flow per Share
107.82
Open
44.19M
Number of Shares
108.92
Day High
99.64%
Free Float in %
94.49
Book Value
630.7K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Feb 09, 2026107.82108.92104.03106.21741.42K
Feb 06, 2026105.55108.95104.88108.42764.87K
Feb 05, 2026106.40107.16104.71105.89786.6K
Feb 04, 2026102.94106.11101.87106.00924.35K
Feb 03, 2026102.56104.26101.65102.371.68M
Feb 02, 2026103.69104.87102.81103.361.08M
Jan 30, 2026105.17106.98103.52104.371.31M
Jan 29, 2026104.71105.88102.95105.48957.18K
Jan 28, 2026105.76106.66103.52105.331.29M
Jan 27, 2026104.89106.24103.80104.521.44M
Jan 26, 2026103.03105.42103.01104.20735.68K
Jan 23, 2026104.91105.45102.48103.40707.83K
Jan 22, 2026103.86107.06103.23105.09864.12K
Jan 21, 2026101.19103.49101.01102.96958.4K
Jan 20, 2026101.53102.04100.18100.34904.45K
Jan 16, 2026103.70104.45102.69103.00819.21K
Jan 15, 2026102.73106.53102.68104.61968.46K
Jan 14, 2026103.65104.97102.86103.051.07M
Jan 13, 2026108.56109.19103.84103.901.08M
Jan 12, 2026112.90112.90108.30108.561.36M

Contact Details

Wayne, PA 19087-1603

United States

https://www.teleflex.com610 225 6800

About Company

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Company Information

Employees14100
Beta0.91
Sales or Revenue$2.97B
5Y Sales Change%0.181%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Instruments & Supplies

Technical Performance

TFX has shown weak momentum, losing -7.57% over the past week and -21.69% over the past quarter, though year-to-date performance is down -17.78%. Short-term trend indicators are bullishly aligned (SMA20 1.58%, SMA50 -7.61%, SMA200 -11.61%). The stock’s 14-day RSI is 45.24 (neutral), while the ATR of 3.6 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -41.18% below its high and over 6.02% above its low. Average 10-day trading volume of 1.04 million shares is slightly above the 3-month average of 812.29 thousand, indicating heightened recent market interest.

Dividend & Fair Value

Teleflex Incorporated last paid a dividend of 1.36 per share, this equals a trailing yield of roughly 0.59%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $312.49. This means the shares are trading below this model’s fair value.

Shareholding & Insider Activity

Teleflex Incorporated has 44.19 million shares outstanding. The public float is 44.03 million shares, elevated short interest at 3.41% of float. This equals 935.70 thousand shares. The short ratio is 1.6 days. Institutional investors hold 108.36% of the float. Insiders own 0.33%. SMITH BENSON holds 48.81 thousand shares, Kelly Liam has 45.27 thousand shares and Leyden James J has 15.89 thousand shares.

Frequently Asked Questions

What is the current Teleflex Incorporated (TFX) stock price?
Teleflex Incorporated (NYSE: TFX) stock price is $106.21 in the last trading session. During the trading session, TFX stock reached the peak price of $108.92 while $104.03 was the lowest point it dropped to. The percentage change in TFX stock occurred in the recent session was -2.04% while the dollar amount for the price change in TFX stock was - $2.21.
TFX's industry and sector of operation?
The NYSE listed TFX is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. Teleflex Incorporated designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of TFX?
Ms. Michelle Fox
Corporation Vice President & Chief Medical Officer
Mr. Howard Cyr
Corporation Vice President & Chief Compliance Officer
Mr. Jay White
Corporation Vice President & Pres of Global Commercial
Mr. Cameron P. Hicks
Corporation Vice President of HR & Communications
Mr. Daniel V. Logue
Corporation Vice President, Gen. Counsel & Sec.
Mr. Liam J. Kelly
Chairman, Pres & Chief Executive Officer
Mr. Thomas E. Powell
Executive Vice President & Chief Financial Officer
Mr. John Hsu C.F.A.
Vice President of Investor Relations
Mr. James P. Winters
Corporation Vice President, Manufacturing and Supply Chain
Mr. John R. Deren
Corporation Vice President & Chief Accounting Officer
Mr. Matt Tomkin
Vice President of Corporation Devel.
Mr. Timothy F. Duffy
Vice President & Chief Information Officer
How TFX did perform over past 52-week?
TFX's closing price is 6.02% higher than its 52-week low of $100.18 where as its distance from 52-week high of $180.58 is -41.18%.
How many employees does TFX have?
Number of TFX employees currently stands at 14,100.
Link for TFX official website?
Official Website of TFX is: https://www.teleflex.com
How do I contact TFX?
TFX could be contacted at phone 610 225 6800 and can also be accessed through its website. TFX operates from 550 East Swedesford Road, Wayne, PA 19087-1603, United States.
How many shares of TFX are traded daily?
TFX stock volume for the day was 630.7K shares. The average number of TFX shares traded daily for last 3 months was 842.54K.
What is the market cap of TFX currently?
The market value of TFX currently stands at $4.69B with its latest stock price at $106.21 and 44.19M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph